Nektar Therapeutics
NKTR
#6602
Rank
HK$5.61 B
Marketcap
HK$275.83
Share price
-1.59%
Change (1 day)
181.02%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): -HK$62.22

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$62.21. In 2024 the company made an earnings per share (EPS) of -HK$69.15 an increase over its 2023 EPS that were of -HK$170.93.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$62.22-10.02%
2024-HK$69.15-59.54%
2023-HK$170.93-25.89%
2022-HK$230.64-31.12%
2021-HK$334.8414.86%
2020-HK$291.52-1.19%
2019-HK$295.04-163.96%
2018HK$461.28-725.4%
2017-HK$73.76-42.73%
2016-HK$128.7983.33%
2015-HK$70.2539.53%
2014-HK$50.34-69.29%
2013-HK$163.91-6.67%
2012-HK$175.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.48-230.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.42-121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$101.70-263.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-HK$5.15-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.27-195.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$23.69-138.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
HK$0.55-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
HK$16.16-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland